Common TitleCOMMAND-4
Official Title Randomized Controlled Trial of the NS5A Inhibitor Daclatasvir plus Pegylated Interferon and Ribavirin for HCV Genotype-4 (COMMAND-4)
Phase Phase III
ClinicalTrials.gov NCT01448044
Treatments
Daclatasvir
Daclatasvir
Tradename:DaklinzaOther Names:DCVClass:DiscontinuedFunding
IndustryBristol-Myers Squibb